Coherus BioSciences
| Region | Nordamerika |
| ISIN | US19249H1032 |
| Sektor | Biotechnologie |
| Website | https://www.coherus.com/ |
Coherus BioSciences is a leading developer of high-quality biosimilar therapeutics.
| Titel | Autor | Datum |
|---|---|---|
|
Milliardenmarkt Biosimilars
8 Kommentare |
Harry1 | vor ungefähr 8 Jahren |
| Titel | Datum |
|---|---|
| Oppenheimer reiterates Coherus Biosciences stock rating at Outperform | vor 25 Tagen |
| Coherus outlines $175M annualized LOQTORZI target by 2028 as commercial expansion accelerates | vor 25 Tagen |
| Coherus Oncology, Inc. - 10-K, Annual Report | vor 25 Tagen |
| Coherus Oncology, Inc. - 8-K, Current Report | vor 25 Tagen |
| Coherus BioSciences Non-GAAP EPS of -$0.34 misses by $0.03, revenue of $12.7M misses by $1.39M | vor 25 Tagen |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Coca-Cola (1 Artikel) | |
| Cisco Systems (1 Artikel) | |
| Commerzbank (1 Artikel) | |
| Contact Gold (2 Artikel) | |
| Alle anzeigen | |